Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tania Lobo"'
Autor:
Tania Lobo, Ashley Wilder Smith, David Thissen, George Luta, Carol M. Moinpour, Bryce B. Reeve, Jaeil Ahn, David Cella, Elizabeth A. Hahn, Roxanne E. Jensen, Arnold L. Potosky
Publikováno v:
Journal of Clinical Oncology. 35:1913-1920
Purpose To estimate cancer population-based reference values in the United States for eight PROMIS (Patient-Reported Outcomes Measurement Information System) domains by age and stage of disease. Patients and Methods For the Measuring Your Health (MY-
Autor:
Julia Friberg, Louis M. Weiner, Chul Kim, Mara Tynan, Kellie Gardner, Mary Chris Ponder, Waseem Ahmed, Deepa S. Subramaniam, Lisa Cusaac, Emily Russell, Kimberly Davis, Tania Lobo, Jillian Thompson, Kathryn L. Taylor, Chan To, Kenneth P. Tercyak, Shelby Fallon
Publikováno v:
J Cancer Surviv
PURPOSE. It is well-established that persistent tobacco use among patients with cancer results in numerous adverse outcomes. However, the assessment and treatment of tobacco use with evidence-based methods has been lacking in cancer care. Our cancer
Autor:
Kathryn L. Taylor, Amy J. Starosta, Charlotte J. Hagerman, Stephen K. Van Den Eeden, George Luta, Richard M. Hoffman, David S. Aaronson, Scott P. Kelly, Amethyst Leimpeter, Tania Lobo, Kimberly Davis, Jun Shan, Catherine Tomko
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 25:1240-1250
Background: Due to the concerns about the overtreatment of low-risk prostate cancer, active surveillance (AS) is now a recommended alternative to the active treatments (AT) of surgery and radiotherapy. However, AS is not widely utilized, partially du
Autor:
Bola F. Ekezue, Tania Lobo, Marc Schwartz, Huei-Ting Tsai, Nandini Selvam, Suzanne C. O'Neill, Claudine Isaacs, Calvin Chao, Arnold L. Potosky, Larry Kessler, Chunfu Liu
Publikováno v:
Journal of the National Comprehensive Cancer Network. 13:1216-1224
BACKGROUND A number of practice guidelines incorporate the use of gene expression profiling (GEP) tests for early-stage, hormone receptor-positive, HER2-negative breast tumors. Few studies describe factors associated with GEP testing in US oncology p
Autor:
Yun-Ling Zheng, Brittany McKinnon, Yvonne Jennings, Dennis Tolsma, Ying Wang, Mahlet G. Tadesse, Martha Trout, Hanfei Xu, Alejandra Hurtado-de-Mendoza, Kristi D. Graves, Vanessa B. Sheppard, Brandi Robinson, Tania Lobo
Publikováno v:
Journal of cancer survivorship : research and practice. 12(1)
Advances in precision medicine (PM) have potential to reduce and/or eliminate breast cancer disparities in both treatment and survivorship. However, compared to white Americans, black Americans are often underrepresented in genetic research. This rep
Autor:
Arnold L. Potosky, Marie-Adele Sorel Kress, Tania Lobo, Roxanne E. Jensen, Andrew N. Satinsky, Huei-Ting Tsai
Publikováno v:
Radiation Oncology (London, England)
Background To examine factors associated with the use of radiation therapy (RT) at the end of life in patients with breast, prostate, or colorectal cancer. Methods Using data from the Surveillance, Epidemiology, and End Results (SEER) – Medicare da